Fostamatinib in chronic immune thrombocytopenia: a profile of its use in the USA.
- DOI
- 10.1007/s40267-018-0551-x
- Published
- 2018
- Container
- Drugs & therapy perspectives : for rational drug selection and use
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s40267-018-0551-x,
title = {Fostamatinib in chronic immune thrombocytopenia: a profile of its use in the USA.},
author = {McKeage K and Lyseng-Williamson KA},
year = {2018},
journal = {Drugs \& therapy perspectives : for rational drug selection and use},
doi = {10.1007/s40267-018-0551-x},
url = {https://doi.org/10.1007/s40267-018-0551-x}
}RIS
TY - JOUR TI - Fostamatinib in chronic immune thrombocytopenia: a profile of its use in the USA. AU - McKeage K AU - Lyseng-Williamson KA PY - 2018 JO - Drugs & therapy perspectives : for rational drug selection and use DO - 10.1007/s40267-018-0551-x UR - https://doi.org/10.1007/s40267-018-0551-x ER -
APA
K, M., & KA, L. (2018). Fostamatinib in chronic immune thrombocytopenia: a profile of its use in the USA.. Drugs & therapy perspectives : for rational drug selection and use. https://doi.org/10.1007/s40267-018-0551-x
Source records
- pubmed · retrieved 2026-09-27T15:44:23.421Z
- europe-pmc · retrieved 2026-09-27T15:44:23.443Z